What were the Benefits of Attending?

• Listen to leading experts presenting the latest international research and developments in the field of Autism.

• Learn practical approaches to supporting people with ASD.

• Network with professional colleagues from around the world.

• Get fresh information to help inspire families affected by an Autism Spectrum Disorder.

 

Who Attended

• Education and teaching professionals

• Psychologists, speech pathologists, occupational therapists and other allied occupations

• Academics and students

• Health Professionals, including pediatricians, psychiatrists, neurologists, geneticists, etc.

• Chief Executive Officers, directors and senior managers who provide services to children and adults with Autism.

• Families and care-givers of people with Autism.

​

List of Speakers

Welcoming Remarks:

Joshua Weinstein, Ph.D., M.B.A.ICare4Autism Founder & CEO, USA, Israel

​

Neuropsychopharmacology of Oxytocin and Inflammation in Autism

Eric Hollander, M.D. Clinical Professor of Psychiatry and Director of OCD and Autism Spectrum Program, Montefiore Medical Center and Einstein, Chairman of the Advisory Committee for ICare4Autism
 

Electrophysiology and Endophenotyping of Autism

John Foxe, Ph.D. Research Director of the Children’s Evaluation and Rehabilitation Center (CERC) and Professor of Pediatrics and of Neuroscience at Einstein

​

The Locus Coeruleus/Noradrenergic Hypothesis of Autism

Dominick P. Purpura, M.D. Dean Emeritus, Professor of Neuroscience, Einstein

​

Epilepsy and Autism

Shlomo Shinnar, M.D., Ph.D. Professor of Neurology and Pediatrics, Hyman Climenko Professor of Neuroscience Research, and Director of the Comprehensive Epilepsy Management Center at Montefiore Medical Center and Einstein

​

Genetics of Autism

Robert W. Marion, M.D. Director of the Children’s Evaluation and Rehabilitation Center (CERC) and Professor of Genetics, Einstein

​

Autism Genetics – from Molecules to Pathways

Brett S. Abrahams, Ph.D.Assistant Professor, Departments of Genetics & Neuroscience at Einstein

Leading a Campaign for a Better World for People with Autism

Mark Lever, Chief Executive, The National Autistic Society (NAS), UK

Intervention Targeting Development of Socially Synchronous Engagement in Toddlers with ASD: A Randomized Controlled Trial
Rebecca J. Landa, Ph.D., CCC-SLP Founding Director of Kennedy Krieger’s Center for Autism and Related Disorders and Professor of Psychiatry and Behavioral Sciences in the Johns Hopkins University School of Medicine. 

 

The Ecological Assessment of Executive Function in Autism; the Behavior Rating Inventory of Executive Function – Adult Version

Stefano Pallanti, M.D., Ph.D., Professor of Psychiatry University of Florence and at Mount Sinai School of Medicine, Director of the Residency Program at University of Florence Chair of the Consultation Psychiatry Unit

​

A Novel and Common Inborn Error of Metabolism Discovered in Autism Patients

Arthur L. Beaudet, M.D. Henry and Emma Meyer Professor and Chair Department of Molecular and Human Genetics, Baylor College of Medicine

​

The Welsh Government’s National ASD Strategy (2008): What Can We Learn from the World’s First Government Strategy for Autism?

Hugh Morgan, MMedSc OBE FRSA CEO Autism Wales & Expert Advisor for ASD to the Welsh Assembly Government, Cardiff, Wales